SCHEMBL13792168

SCHEMBL13792168

CCCn1c(CCCc2ccc(OC)cc2)cn(Cc2ccc(Cl)c(Cl)c2)c1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PROKR1 Q8TCW9 2/20 0.43
PPARG P37231 1/20 0.40
PPARD Q03181 1/20 0.40
PPARA Q07869 1/20 0.40
CCR2 P41597 2/20 0.39
MAPT P10636 3/20 0.39
TP53 P04637 2/20 0.39
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
LMNA P02545 3/20 0.38
NPBWR1 P48145 1/20 0.38
ALDH1A1 P00352 2/20 0.37
P2RX7 Q99572 2/20 0.37
HTT P42858 1/20 0.37
UBE2N P61088 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CYP11B1 P15538 1/20 0.36
CYP11B2 P19099 1/20 0.36
PDE1A P54750 1/20 0.36
PDE1B Q01064 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13793172 0.88 CYP11B1 (0.40) PROKR1PPARGPPARDPPARACYP11B1
SCHEMBL13793077 0.88 MAPT (0.55) PPARGPPARDPPARAMAPTTP53
SCHEMBL13792172 0.88 LMNA (0.38) PROKR1CCR2MAPTTP53LMNA
SCHEMBL13793121 0.87 PPARA (0.46) PPARGPPARDPPARAMAPTCYP11B1
SCHEMBL13792802 0.87 SIGMAR1 (0.44) PROKR1PPARGPPARDPPARAMAPT
SCHEMBL13792829 0.87 NPBWR1 (0.41) PROKR1PPARGPPARDPPARAMAPT
SCHEMBL13793093 0.87 PPARG (0.40) PPARGPPARDPPARAMAPTTP53
SCHEMBL13792201 0.86 RGS4 (0.45) PROKR1MAPTKMT2AMEN1LMNA
SCHEMBL13793056 0.86 KMT2A (0.42) PPARGPPARDPPARAMAPTTP53
SCHEMBL13792152 0.86 ALDH1A1 (0.43) PPARGPPARDPPARAMAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7544812-B2 For example, 2-(4-{2-[1-(4-tert-Butyl-benzyl)-3-methyl-2-oxo-imidazolidin-4-yl]-ethoxy}-2-methyl-phenoxy)-2-methyl-propionic acid, 2-(4-{3-[1-(4-tert-Butyl-benzyl)-3-methyl-2-oxo-imidazolidin-4-yl]-propyl}-2-methyl-phenoky)-2-methyl-propionic acid; for treating diabetes mellitus ELI LILLY AND COMPANY (US) 2009-06-09 US disclosed
US-7544812-B2 For example, 2-(4-{2-[1-(4-tert-Butyl-benzyl)-3-methyl-2-oxo-imidazolidin-4-yl]-ethoxy}-2-methyl-phenoxy)-2-methyl-propionic acid, 2-(4-{3-[1-(4-tert-Butyl-benzyl)-3-methyl-2-oxo-imidazolidin-4-yl]-propyl}-2-methyl-phenoky)-2-methyl-propionic acid; for treating diabetes mellitus ELI LILLY AND COMPANY (US) 2009-06-09 US disclosed